HLA-A*02:01-POSITIVE
Clinical trials for HLA-A*02:01-POSITIVE explained in plain language.
Never miss a new study
Get alerted when new HLA-A*02:01-POSITIVE trials appear
Sign up with your email to follow new studies for HLA-A*02:01-POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug, IMC-P115C, designed to help the immune system find and attack cancer cells that have a protein called PRAME. It is for people with advanced solid tumors who have a specific genetic marker (HLA-A*02:01) and have tried other treatments. The …
Matched conditions: HLA-A*02:01-POSITIVE
Phase: PHASE1 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug, IMC-R117C, in people with advanced colorectal, esophageal, stomach, or ovarian cancers that have a specific protein (PIWIL1) and a certain immune type (HLA-A*02:01). The goal is to see if the drug is safe and can shrink tumors. About 600 a…
Matched conditions: HLA-A*02:01-POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Immunocore Ltd • Aim: Disease control
Last updated May 15, 2026 11:55 UTC